No earnings within 2 weeks of this transaction.
| Insider | Bredt David |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Jan 15, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 16, 2026 |
| Shares Sold | 8,300 |
| Price per Share | $26.83 |
| Total Value | $222,651.65 |
| Shares Owned After | 395,775 |
| Derivative | No |
| Accession Number | 0001193125-26-015350 |
| Document | View SEC Filing |